Comparison

Tofisopam (Standard) European Partner

Item no. HY-A0165R-10mg
Manufacturer MedChem Express
CASRN 22345-47-7
Amount 10 mg
Quantity options 1 ea 100 mg 10 mg 25 mg 50 mg 5 mg
Category
Type Standard
Specific against other
Citations [1]Umut İrfan Üçel, et al. Antiamnesic effects of tofisopam against scopolamine-induced cognitive impairments in rats. Pharmacol Biochem Behav. 2020 Mar;190:172858.
Smiles CC1=NN=C(C2=CC=C(OC)C(OC)=C2)C3=CC(OC)=C(OC)C=C3C1CC
ECLASS 10.1 42021590
ECLASS 11.0 42021590
UNSPSC 12352202
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference Standards
Manufacturer - Targets
Phosphodiesterase (PDE); Reference Standards
Shipping Temperature
Room temperature
Molecular Weight
382.45
Product Description
Tofisopam (Standard) is the analytical standard of Tofisopam (HY-A0165). This product is intended for research and analytical applications. Tofisopam, a 2, 3-benzodiazepine compound, is an orally active anxiolytic agent. Tofisopam can inhibit phosphodiesterase PDE isoenzyme activity, withIC50 values of 2.11 μM, 1.98 μM, 0.42 μM, and 0.92 μM for PDE-2A3, PDE-3A, PDE-4A1, and PDE-10A1, respectively. Tofisopam can be used for the study of anxiety[1][2].
Manufacturer - Research Area
Neurological Disease
Manufacturer - Pathway
Metabolic Enzyme/Protease; Others
Isoform
PDE10; PDE2; PDE3; PDE4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close